4.6 Review

Role of Astrocytes in the Pathophysiology of Lafora Disease and Other Glycogen Storage Disorders

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Clinical Neurology

Glycogen synthase downregulation rescues the amylopectinosis of murine RBCK1 deficiency

Silvia Nitschke et al.

Summary: This study investigates the influence of glucan chain length on precipitation and the disease caused by abnormal glycogen structure. The authors found that the glycogen pathology of RBCK1 deficiency is similar to malin-deficient Lafora disease and can be rescued by downregulating glycogen synthase.
Review Neurosciences

Phagocytic astrocytes: Emerging from the shadows of microglia

Hiroyuki Konishi et al.

Summary: This study discusses the role and consequences of astrocytic phagocytosis, focusing on its differences from microglial phagocytosis and how these two phagocytic systems cooperate.
Article Neurosciences

Lack of p62 Impairs Glycogen Aggregation and Exacerbates Pathology in a Mouse Model of Myoclonic Epilepsy of Lafora

Pasquale Pellegrini et al.

Summary: Lafora disease (LD) is a fatal childhood-onset dementia characterized by the accumulation of glycogen aggregates in various organs, particularly in the brain. The presence of p62, an autophagy adaptor, plays a role in the formation of these aggregates, suggesting a protective mechanism to mitigate the harmful consequences of glycogen accumulation in the brain.

MOLECULAR NEUROBIOLOGY (2022)

Article Biochemistry & Molecular Biology

HOIL-1 ubiquitin ligase activity targets unbranched glucosaccharides and is required to prevent polyglucosan accumulation

Ian R. Kelsall et al.

Summary: The E3 ligase activity of HOIL-1 is essential for preventing the accumulation of toxic polysaccharide deposits, as it ubiquitylates serine and threonine residues in proteins. HOIL-1 can monoubiquitylate glycogen and alpha 1:4-linked maltoheptaose, facilitating their removal from cells and preventing the formation of polyglucosan.

EMBO JOURNAL (2022)

Article Clinical Neurology

Proteomic characterisation of polyglucosan bodies in skeletal muscle in RBCK1 deficiency

Christer Thomsen et al.

Summary: This study identified the principal protein components of polyglucosan bodies in PGBM1 using quantitative mass spectrometry, immunohistochemical, and western blot analyses. The accumulated proteins were mainly related to glycogen metabolism and protein quality control pathways, indicating the potential role of protein aggregation in the pathobiology of polyglucosan storage disorders.

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2022)

Article Clinical Neurology

AAV-Mediated Artificial miRNA Reduces Pathogenic Polyglucosan Bodies and Neuroinflammation in Adult Polyglucosan Body and Lafora Disease Mouse Models

Emrah Gumusgoz et al.

Summary: Adult polyglucosan body disease (APBD) and Lafora disease (LD) are two autosomal recessive neurological disorders caused by gene mutations. Both diseases share a common pathology of abnormal glycogen accumulation. By reducing the expression of glycogen synthase, we were able to decrease the formation of pathological polyglucosan bodies and improve early neuroinflammatory markers of disease. This study provides proof of principle for a lifelong treatment for APBD and LD, and may be applicable to other glycogen storage diseases.

NEUROTHERAPEUTICS (2022)

Article Clinical Neurology

Malin restoration as proof of concept for gene therapy for Lafora disease

Olga Varea et al.

Summary: Lafora disease is a fatal childhood dementia caused by mutations in either laforin or malin genes. Restoring malin at an advanced stage of the disease has shown to be an effective treatment.

BRAIN COMMUNICATIONS (2022)

Article Cell Biology

From corpora amylacea to wasteosomes: History and perspectives

Marta Riba et al.

Summary: The article summarizes research findings on CA in human organs and proposes that CA may function as waste containers created by specific cells to sequester waste and foreign products in glycan structures, which are then secreted and phagocytosed. The proposal aims to explain the varied content of CA, the presence of fibrillary amyloid proteins in some but not all CA, and the intracellular or extracellular nature of CA structures. It also suggests renaming CA as "wasteosomes" to emphasize their role in trapping waste rather than their misleading amyloid properties.

AGEING RESEARCH REVIEWS (2021)

Article Neurosciences

Modulators of Neuroinflammation Have a Beneficial Effect in a Lafora Disease Mouse Model

Belen Molla et al.

Summary: Lafora disease is a fatal rare neurodegenerative disorder characterized by epileptic seizures and polyglucosan inclusions in the brain. It is caused by mutations in two genes and currently lacks appropriate treatment. Neuroinflammation has been identified as a key factor, and anti-inflammatory treatments such as propranolol and EGCG have shown potential therapeutic effects in preclinical studies.

MOLECULAR NEUROBIOLOGY (2021)

Article Neurosciences

Suppression of glycogen synthesis as a treatment for Lafora disease: Establishing the window of opportunity

Olga Varea et al.

Summary: Lafora disease (LD) is a fatal adolescence-onset neurodegenerative condition characterized by the accumulation of aberrant glycogen aggregates known as Lafora bodies (LBs). Early suppression of glycogen synthase (MGS) can prevent LB formation and pathological manifestations of LD, but it is unclear whether late suppression of MGS can halt LB accumulation. Further research is needed to understand the potential therapeutic effects of targeting MGS in LD treatment.

NEUROBIOLOGY OF DISEASE (2021)

Article Clinical Neurology

Gys1 antisense therapy rescues neuropathological bases of murine Lafora disease

Saija Ahonen et al.

Summary: Lafora disease is a fatal progressive myoclonus epilepsy caused by the accumulation of long branches in glycogen molecules leading to the formation of Lafora bodies. In mouse models, targeting the GYS1 mRNA with an antisense oligonucleotide (Gys1-ASO) prevented the formation of Lafora bodies and halted disease progression, showing promise as a potential therapy for this catastrophic epilepsy.
Article Clinical Neurology

Astrocytic glycogen accumulation drives the pathophysiology of neurodegeneration in Lafora disease

Jordi Duran et al.

Summary: Recent studies have shown that Lafora bodies are also present in astrocytes, not only in neurons. Blocking glycogen synthesis in astrocytes prevents the increase in neurodegeneration markers, autophagy impairment, and metabolic changes characteristic of the malin(KO) model.
Article Clinical Neurology

Targeting Gys1 with AAV-SaCas9 Decreases Pathogenic Polyglucosan Bodies and Neuroinflammation in Adult Polyglucosan Body and Lafora Disease Mouse Models

Emrah Gumusgoz et al.

Summary: Many adult and most childhood neurological diseases have a genetic basis, and CRISPR/Cas9 technology shows promise in treating them. By using CRISPR/Cas9 to disrupt gene sequences in adult polyglucosan body disease and Lafora disease mouse models, the researchers were able to reduce abnormal glycogen accumulation and improve neuroinflammatory markers, demonstrating the potential of this therapy for neurological diseases.

NEUROTHERAPEUTICS (2021)

Review Genetics & Heredity

Natural history of Lafora disease: a prognostic systematic review and individual participant data meta-analysis

Federica Pondrelli et al.

Summary: Lafora disease is a rare fatal autosomal recessive form of progressive myoclonus epilepsy that affects previously healthy children or adolescents. The study found that Asian origin and age at onset<18 years are negative prognostic factors. It also documented that half of LD patients survived at least 11 years, highlighting the importance of understanding actual survival rates and prognostic factors for designing upcoming new disease-modifying therapies.

ORPHANET JOURNAL OF RARE DISEASES (2021)

Article Multidisciplinary Sciences

Reconstitution defines the roles of p62, NBR1 and TAX1BP1 in ubiquitin condensate formation and autophagy initiation

Eleonora Turco et al.

Summary: Misfolded proteins are ubiquitinated and condensed by cargo receptors for selective autophagy. The study elucidates the roles of p62/SQSTM1, NBR1, and TAX1BP1 in the formation and degradation of ubiquitin condensates through autophagy.

NATURE COMMUNICATIONS (2021)

Article Biochemistry & Molecular Biology

An inducible glycogen synthase-1 knockout halts but does not reverse Lafora disease progression in mice

Silvia Nitschke et al.

Summary: The study demonstrates that knocking out Gys1 gene in LD mice can partially halt the progression of the disease but cannot fully reverse neurodegeneration and fatal epilepsy. While Gys1 knockout inhibits glycogen and Lafora body accumulation in skeletal muscle, it has some effect in preventing disease development in the brain. Additional research is needed to explore further mechanisms as glycogen and LBs still accumulate in certain tissues.

JOURNAL OF BIOLOGICAL CHEMISTRY (2021)

Article Chemistry, Applied

Polyglucosan body structure in Lafora disease

M. Kathryn Brewer et al.

CARBOHYDRATE POLYMERS (2020)

Article Neurosciences

Lack of Astrocytic Glycogen Alters Synaptic Plasticity but Not Seizure Susceptibility

Jordi Duran et al.

MOLECULAR NEUROBIOLOGY (2020)

Article Clinical Neurology

GYS1 or PPP1R3C deficiency rescues murine adult polyglucosan body disease

Erin E. Chown et al.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2020)

Article Neurosciences

Lack of Neuronal Glycogen Impairs Memory Formation and Learning-Dependent Synaptic Plasticity in Mice

Jordi Duran et al.

FRONTIERS IN CELLULAR NEUROSCIENCE (2019)

Review Physiology

BRAIN GLUCOSE METABOLISM: INTEGRATION OF ENERGETICS WITH FUNCTION

Gerald A. Dienel

PHYSIOLOGICAL REVIEWS (2019)

Article Biochemistry & Molecular Biology

Astrocytes: new players in progressive myoclonus epilepsy of Lafora type

Carla Rubio-Villena et al.

HUMAN MOLECULAR GENETICS (2018)

Review Biochemistry & Molecular Biology

Lafora disease offers a unique window into neuronal glycogen metabolism

Matthew S. Gentry et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2018)

Article Multidisciplinary Sciences

Exploring the elusive composition of corpora amylacea of human brain

Elisabet Auge et al.

SCIENTIFIC REPORTS (2018)

Article Clinical Neurology

Lafora Disease: A Review of Molecular Mechanisms and Pathology

Brandy Verhalen et al.

NEUROPEDIATRICS (2018)

Review Biochemistry & Molecular Biology

Pathogenesis of Lafora Disease: Transition of Soluble Glycogen to Insoluble Polyglucosan

Mitchell A. Sullivan et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)

Article Multidisciplinary Sciences

New perspectives on corpora amylacea in the human brain

Elisabet Auge et al.

SCIENTIFIC REPORTS (2017)

Article Medicine, Research & Experimental

Abnormal glycogen chain length pattern, not hyperphosphorylation, is critical in Lafora disease

Felix Nitschke et al.

EMBO MOLECULAR MEDICINE (2017)

Article Medicine, General & Internal

Glycogen metabolism in humans

Maria M. Adeva-Andany et al.

BBA CLINICAL (2016)

Article Biochemistry & Molecular Biology

A novel mouse model that recapitulates adult-onset glycogenosis type 4

H. Orhan Akman et al.

HUMAN MOLECULAR GENETICS (2015)

Article Medicine, General & Internal

Parkinson's disease

Lorraine V. Kalia et al.

LANCET (2015)

Review Biochemistry & Molecular Biology

Glycogen phosphorylation and Lafora disease

Peter J. Roach

MOLECULAR ASPECTS OF MEDICINE (2015)

Article Medicine, Research & Experimental

Role of Astrocytes in Epilepsy

Douglas A. Coulter et al.

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2015)

Article Endocrinology & Metabolism

Contributions of glycogen to astrocytic energetics during brain activation

Gerald A. Dienel et al.

METABOLIC BRAIN DISEASE (2015)

Article Endocrinology & Metabolism

Does abnormal glycogen structure contribute to increased susceptibility to seizures in epilepsy?

Mauro DiNuzzo et al.

METABOLIC BRAIN DISEASE (2015)

Article Cell Biology

Neuronal glycogen synthesis contributes to physiological aging

Christopher Sinadinos et al.

AGING CELL (2014)

Article Clinical Neurology

PTG protein depletion rescues malin-deficient Lafora disease in mouse

Julie Turnbull et al.

ANNALS OF NEUROLOGY (2014)

Article Biochemistry & Molecular Biology

Glycogen accumulation underlies neurodegeneration and autophagy impairment in Lafora disease

Jordi Duran et al.

HUMAN MOLECULAR GENETICS (2014)

Article Endocrinology & Metabolism

Neurons have an active glycogen metabolism that contributes to tolerance to hypoxia

Isabel Saez et al.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2014)

Article Neurosciences

Loss of GABAergic cortical neurons underlies the neuropathology of Lafora disease

Saida Ortolano et al.

MOLECULAR BRAIN (2014)

Article Clinical Neurology

Polyglucosan Body Myopathy Caused by Defective Ubiquitin Ligase RBCK1

Johanna Nilsson et al.

ANNALS OF NEUROLOGY (2013)

Article Endocrinology & Metabolism

Impairment in long-term memory formation and learning-dependent synaptic plasticity in mice lacking glycogen synthase in the brain

Jordi Duran et al.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2013)

Article Clinical Neurology

Adult polyglucosan body disease: Natural History and Key Magnetic Resonance Imaging Findings

Fanny Mochel et al.

ANNALS OF NEUROLOGY (2012)

Article Medicine, Research & Experimental

Deleterious effects of neuronal accumulation of glycogen in flies and mice

Jordi Duran et al.

EMBO MOLECULAR MEDICINE (2012)

Article Neurosciences

Ontogeny of Lafora bodies and neurocytoskeleton changes in Laforin-deficient mice

Jesus Machado-Salas et al.

EXPERIMENTAL NEUROLOGY (2012)

Article Biochemistry & Molecular Biology

Dysfunctions in endosomal-lysosomal and autophagy pathways underlie neuropathology in a mouse model for Lafora disease

Rajat Puri et al.

HUMAN MOLECULAR GENETICS (2012)

Article Biochemistry & Molecular Biology

Lafora bodies and neurological defects in malin-deficient mice correlate with impaired autophagy

Olga Criado et al.

HUMAN MOLECULAR GENETICS (2012)

Article Clinical Neurology

Laforin and Malin Deletions in Mice Produce Similar Neurologic Impairments

Ana M. Garcia-Cabrero et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2012)

Article Biochemistry & Molecular Biology

Astrocyte-Neuron Lactate Transport Is Required for Long-Term Memory Formation

Akinobu Suzuki et al.

Article Medicine, Research & Experimental

Neurodegeneration and functional impairments associated with glycogen synthase accumulation in a mouse model of Lafora disease

Jordi Valles-Ortega et al.

EMBO MOLECULAR MEDICINE (2011)

Article Genetics & Heredity

PTG Depletion Removes Lafora Bodies and Rescues the Fatal Epilepsy of Lafora Disease

Julie Turnbull et al.

PLOS GENETICS (2011)

Article Biochemistry & Molecular Biology

Laforin, the most common protein mutated in Lafora disease, regulates autophagy

Carmen Aguado et al.

HUMAN MOLECULAR GENETICS (2010)

Article Biochemistry & Molecular Biology

Genetic Depletion of the Malin E3 Ubiquitin Ligase in Mice Leads to Lafora Bodies and the Accumulation of Insoluble Laforin

Anna A. DePaoli-Roach et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2010)

Editorial Material Biochemistry & Molecular Biology

To aggregate or not to aggregate? A new role for p62

Jorge Moscat et al.

EMBO REPORTS (2009)

Article Biochemistry & Molecular Biology

Regulation of glycogen synthesis by the laforin-malin complex is modulated by the AMP-activated protein kinase pathway

Maria Carmen Solaz-Fuster et al.

HUMAN MOLECULAR GENETICS (2008)

Article Biochemistry & Molecular Biology

Malin decreases glycogen accumulation by promoting the degradation of protein targeting to glycogen (PTG)

Carolyn A. Worby et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2008)

Review Biochemistry & Molecular Biology

Brain glycogen re-awakened

AM Brown

JOURNAL OF NEUROCHEMISTRY (2004)

Article Genetics & Heredity

Mutations in NHLRC1 cause progressive myoclonus epilepsy

EM Chan et al.

NATURE GENETICS (2003)

Review Clinical Neurology

Lafora's disease: Towards a clinical, pathologic, and molecular synthesis

BA Minassian

PEDIATRIC NEUROLOGY (2001)

Article Clinical Neurology

Extensive white-matter changes in case of adult polyglucosan body disease

M Berkhoff et al.

NEURORADIOLOGY (2001)